News India Cracks Down On Misleading Promotion Of Obesity Drugs, Orders Monthly GLP-1 Safety Review The move comes as semaglutide goes generic in India, triggering a surge in demand and concerns over misleading promotion.Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Like this:Like Loading… Post navigation Previous: ‘Mentally Strong’: How A Missing Techie Was Found Alive In Kodagu Hills After Intense 3-Day SearchNext: SC Orders CBI Preliminary Probe Into Contracts Linked To Arunachal CM Pema Khandu’s Family More Stories News ‘Smaller Convoy For PM Modi Is Not A Good Idea’: Former R&AW Chief Explains Why | Exclusive News PM Modi’s Economic Advisor Sanjeev Sanyal Frontrunner For Bengal Finance Minister Post: Report News Maharashtra CM Fadnavis Ditches Private Jet, Travels Economy After PM Modi’s Conserve Fuel Appeal